Advances in Malaria Vaccine Development: Report from the 2017 Malaria Vaccine Symposium

Overview

Journal NPJ Vaccines

Date 2018 Mar 10

PMID 29522056

Citations 36

Authors

Camila Henriques Coelho

Justin Yai Alamou Doritchamou

Irfan Zaidi

Patrick E Duffy

Affiliations

Soon will be listed here.

Abstract

The Malaria Vaccine Symposium occurred at Johns Hopkins University in Baltimore, MD, USA on April 25th, 2017, coinciding with World Malaria Day and the WHO announcement that the RTS,S malaria vaccine would begin pilot implementation programs in Ghana, Kenya, and Malawi in 2018. Scientists from several disciplines reported progress on an array of malaria vaccine concepts and product candidates, including pre-erythrocytic vaccines that prevent infection, blood-stage vaccines that limit infection and disease, and transmission-blocking vaccines that interrupt the spread of infection. Other speakers highlighted the immunological and genetic considerations that must be addressed by vaccinologists to yield the most efficacious vaccines. Here, we highlight the advances in malaria vaccinology that were reported at the symposium.

Citing Articles

Gossypol is a natural product with good antimalarial activity against Plasmodium falciparum clinical isolates.

Chirawurah J, Ansah F, Blankson S, Adikah B, Yeboah S, Amenga-Etego L Sci Rep. 2025; 15(1):1469.

PMID: 39789096 PMC: 11718166. DOI: 10.1038/s41598-025-85643-6.

Antibody gene features associated with binding and functional activity in malaria vaccine-derived human mAbs.

Coelho C, Marquez S, Nguemwo Tentokam B, Berhe A, Miura K, Rao V NPJ Vaccines. 2024; 9(1):144.

PMID: 39127706 PMC: 11316794. DOI: 10.1038/s41541-024-00929-6.

Natural Infection Stimulates Human Antibodies to MSP1 Epitopes Identified in Mice Infection Models upon Non-Natural Modified Peptidomimetic Vaccination.

Rodriguez Z, Melo F, Torres A, Agrawal N, Cortes-Vecino J, Lozano J Molecules. 2023; 28(6).

PMID: 36985500 PMC: 10057838. DOI: 10.3390/molecules28062527.

Patient variability in the blood-stage dynamics of Plasmodium falciparum captured by clustering historical data.

Masserey T, Penny M, Lee T Malar J. 2022; 21(1):300.

PMID: 36289505 PMC: 9608883. DOI: 10.1186/s12936-022-04317-0.

Collection and Cryopreservation of Plasmodium falciparum Clinical Isolates in the Field.

Partey F, Frimpong A, Ofori M Methods Mol Biol. 2022; 2470:11-17.

PMID: 35881334 DOI: 10.1007/978-1-0716-2189-9_2.

References

Hjerrild K, Jin J, Wright K, Brown R, Marshall J, Labbe G . Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system. Sci Rep. 2016; 6:30357. PMC: 4960544. DOI: 10.1038/srep30357. View

Agnandji S, Lell B, Fernandes J, Abossolo B, Methogo B, Lumeka Kabwende A . A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med. 2012; 367(24):2284-95. PMC: 10915853. DOI: 10.1056/NEJMoa1208394. View

Kurup S, Obeng-Adjei N, Anthony S, Traore B, Doumbo O, Butler N . Regulatory T cells impede acute and long-term immunity to blood-stage malaria through CTLA-4. Nat Med. 2017; 23(10):1220-1225. PMC: 5649372. DOI: 10.1038/nm.4395. View

Douglas A, Williams A, Illingworth J, Kamuyu G, Biswas S, Goodman A . The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat Commun. 2011; 2:601. PMC: 3504505. DOI: 10.1038/ncomms1615. View

Macdonald N, Nguyen V, Shimp R, Reiter K, Herrera R, Burkhardt M . Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230. J Biol Chem. 2016; 291(38):19913-22. PMC: 5025679. DOI: 10.1074/jbc.M116.732305. View

Ishizuka A, Lyke K, DeZure A, Berry A, Richie T, Mendoza F . Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nat Med. 2016; 22(6):614-23. PMC: 11294733. DOI: 10.1038/nm.4110. View

Wright K, Hjerrild K, Bartlett J, Douglas A, Jin J, Brown R . Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies. Nature. 2014; 515(7527):427-30. PMC: 4240730. DOI: 10.1038/nature13715. View

Srinivasan P, Ekanem E, Diouf A, Tonkin M, Miura K, Boulanger M . Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria. Proc Natl Acad Sci U S A. 2014; 111(28):10311-6. PMC: 4104859. DOI: 10.1073/pnas.1409928111. View

. Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS Med. 2014; 11(7):e1001685. PMC: 4114488. DOI: 10.1371/journal.pmed.1001685. View

10.

Giddam A, Reiman J, Zaman M, Skwarczynski M, Toth I, Good M . A semi-synthetic whole parasite vaccine designed to protect against blood stage malaria. Acta Biomater. 2016; 44:295-303. DOI: 10.1016/j.actbio.2016.08.020. View

11.

Epstein J, Paolino K, Richie T, Sedegah M, Singer A, Ruben A . Protection against malaria by PfSPZ Vaccine. JCI Insight. 2017; 2(1):e89154. PMC: 5214067. DOI: 10.1172/jci.insight.89154. View

12.

Hoffman S, Vekemans J, Richie T, Duffy P . The march toward malaria vaccines. Vaccine. 2015; 33 Suppl 4:D13-23. PMC: 5634526. DOI: 10.1016/j.vaccine.2015.07.091. View

13.

Molina-Cruz A, Canepa G, Kamath N, Pavlovic N, Mu J, Ramphul U . Plasmodium evasion of mosquito immunity and global malaria transmission: The lock-and-key theory. Proc Natl Acad Sci U S A. 2015; 112(49):15178-83. PMC: 4679011. DOI: 10.1073/pnas.1520426112. View

14.

Carter R, Chen D . Malaria transmission blocked by immunisation with gametes of the malaria parasite. Nature. 1976; 263(5572):57-60. DOI: 10.1038/263057a0. View

15.

Good M, Reiman J, Rodriguez I, Ito K, Yanow S, El-Deeb I . Cross-species malaria immunity induced by chemically attenuated parasites. J Clin Invest. 2013; . PMC: 4011145. DOI: 10.1172/JCI66634. View

16.

Butler N, Schmidt N, Vaughan A, Aly A, Kappe S, Harty J . Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe. 2011; 9(6):451-62. PMC: 3117254. DOI: 10.1016/j.chom.2011.05.008. View

17.

Stanisic D, Good M . Whole organism blood stage vaccines against malaria. Vaccine. 2015; 33(52):7469-75. DOI: 10.1016/j.vaccine.2015.09.057. View

18.

Payne R, Milne K, Elias S, Edwards N, Douglas A, Brown R . Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01. J Infect Dis. 2016; 213(11):1743-51. PMC: 4857475. DOI: 10.1093/infdis/jiw039. View

19.

Raja A, Stanisic D, Good M . Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine. Infect Immun. 2017; 85(7). PMC: 5478957. DOI: 10.1128/IAI.00062-17. View

20.

Seder R, Chang L, Enama M, Zephir K, Sarwar U, Gordon I . Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science. 2013; 341(6152):1359-65. DOI: 10.1126/science.1241800. View